High-dose iodized oil transcatheter arterial chemoembolization for patients with large hepatocellular carcinoma

Table 1 Pretreatment clinical characteristics of 473 patients

Characteristics	Group A (N = 216)	Group B (N = 257)	Probability value
Age
Mean	44.6	45.1	0.348
Range	22-67	24-71
Sex
Mate	213	246	0.065
Female	3	11
Diameter of tumor
6-9.9 cm	32	9	0.133
10-14.9 cm	105	135
≥ 15 cm	79	73
Thrombosis
Yes	54	81	0.118
No	162	176
AFP (μg/L)
≥ 400	91	114	0.626
< 400	125	143
ALT
< 40	117	109	0.023
40-79	78	103
80-119	17	39
≥ 120	4	7
Child’s class
A	203	238	0.553
B	13	19
ICG-R15*
< 10	71	89	0.314
10-19	127	137
20-29	18	31

*ICG-R15 refers to the indocyanine green retention rate at 15 minutes

Table 2 The comparison of liver dysfunction** in two group

Group	Child-Pugh Classification		ICG-R15
	A	B	< 10%	10%-19%	≥ 20%
Group A	5.9%(12/203)	92.3%(12/13)	1.4%(1/71)	7.9%(10/127)	72.2%(13/18)
Group B	5.5%(13/238)	84.2%(15/19)	2.2%(2/89)	5.8%(8/137)	58.1%(18/31)

**Liver dysfunction is refereed to ascites, jaundice(Tbil > 34.2 μmol/L), or hepatic encephalopaphy